Kristin Stephens Syros Pharmaceuticals, Inc. (SYRS) insider trading activity

SYRS Quotes by TradingView

Kristin Stephens is Chief Development Officer of Syros Pharmaceuticals, Inc.. Currently has a direct ownership of 36,133 shares of SYRS, which is worth approximately $7,587. The most recent transaction as insider was on Oct 31, 2024, when has been sold 6,104 shares (Common Stock) at a price of $2.09 per share, resulting in proceeds of $12,757. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 36.1K
43.17% 3M change
128.85% 12M change
Total Value Held $7,587

Kristin Stephens Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 31 2024
SELL
Payment of exercise price or tax liability
$12,757 $2.09 p/Share
6,104 Reduced 14.45%
36,133 Common Stock
Oct 31 2024
BUY
Exercise of conversion of derivative security
-
17,000 Added 28.7%
42,237 Common Stock
Apr 01 2024
SELL
Payment of exercise price or tax liability
$21,596 $5.12 p/Share
4,218 Reduced 14.32%
25,237 Common Stock
Mar 31 2024
BUY
Exercise of conversion of derivative security
-
13,666 Added 31.69%
29,455 Common Stock
Nov 01 2023
SELL
Payment of exercise price or tax liability
$12,600 $2.22 p/Share
5,676 Reduced 26.44%
15,789 Common Stock
Oct 31 2023
BUY
Exercise of conversion of derivative security
-
17,000 Added 44.2%
21,465 Common Stock
Apr 03 2023
SELL
Payment of exercise price or tax liability
$1,607 $2.58 p/Share
623 Reduced 12.24%
4,465 Common Stock
Mar 31 2023
BUY
Exercise of conversion of derivative security
-
2,000 Added 28.22%
5,088 Common Stock
Apr 01 2022
SELL
Payment of exercise price or tax liability
$15,809 $1.12 p/Share
14,115 Reduced 31.37%
30,885 Common Stock
KS

Kristin Stephens

Chief Development Officer
Cambridge, MA

Track Institutional and Insider Activities on SYRS

Follow Syros Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SYRS shares.

Notify only if

Insider Trading

Get notified when an Syros Pharmaceuticals, Inc. insider buys or sells SYRS shares.

Notify only if

News

Receive news related to Syros Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SYRS